Mr. Mainville is also Chair of the board of directors of Zucara Therapeutics Inc. Previously, Mr. Mainville served as Executive Vice President for Cardiome Pharma Corp. as well as President and Chief Executive Officer of Neopharm Labs Inc. and prior to that LAB Research Inc. He has gained considerable experience throughout his career in senior management, operational and corporate finance roles, and served as a director for a number of public and private companies in the biotechnology and pharmaceutical sectors. In particular, Mr. Mainville has led in excess of 20 public company financing transactions, totaling funds raised in excess of $200 million, as well as served as Chair and Chair of the Audit Committee for a number of Boards. He served as Vice-Chairman of BioteCanada and, prior to his career in the life science industry, Mr. Mainville was a Senior Vice President and Partner at KPMG. Mr. Mainville is also Chair of the board of directors of Zucara Therapeutics Inc. Previously, Mr. Mainville served as Executive Vice President for Cardiome Pharma Corp. as well as President and Chief Executive Officer of Neopharm Labs Inc. and prior to that LAB Research Inc. He has gained considerable experience throughout his career in senior management, operational and corporate finance roles, and served as a director for a number of public and private companies in the biotechnology and pharmaceutical sectors. In particular, Mr. Mainville has led in excess of 20 public company financing transactions, totaling funds raised in excess of $200 million, as well as served as Chair and Chair of the Audit Committee for a number of Boards. He served as Vice-Chairman of BioteCanada and, prior to his career in the life science industry, Mr. Mainville was a Senior Vice President and Partner at KPMG.

Reproductive Medicine, Pharmaceutical Products